Opportunity

Federal Register #2026-10931

NIH Monoclonal Antibody Licensing and Data Collection Enhancement Award

Buyer

Department of Health and Human Services, National Institutes of Health

Posted

June 01, 2026

Identifier

2026-10931

NAICS

541714, 541715, 325414

This opportunity summary covers recent activities by the Department of Health and Human Services, specifically the National Institutes of Health (NIH) and its sub-agencies: - Government Buyer: - Department of Health and Human Services - National Institutes of Health (NIH) - Sub-agencies: National Eye Institute, National Institute of Allergy and Infectious Diseases (NIAID) - OEMs and Vendors: - National Institute of Allergy and Infectious Diseases (NIAID) (as developer of monoclonal antibody 18H2) - University of Illinois, Chicago (award recipient for data collection enhancement) - Products/Services Requested: - Monoclonal antibody 18H2 for detection of transcription factor Eos in regulatory T cells - Developed by NIAID - No part number or quantity specified - Intended for research in autoimmunity, cancer, and transplantation - Data collection and analysis enhancement services for the Black Lung Clinics Program - Provided by University of Illinois, Chicago - 1 service instance funded - Unique or Notable Requirements: - The monoclonal antibody 18H2 is available for licensing, targeting research applications in immunology and oncology - The data collection enhancement is focused on improving patient-level data and clinic operations for a federal health program - Locations: - NIH and its sub-agencies in Bethesda and Rockville, MD - University of Illinois, Chicago (award recipient location)

Description

This notice announces closed meetings scheduled for June 29-30, 2026, organized by the Department of Health and Human Services and the National Institutes of Health. The meetings are related to the review and evaluation of grant applications by various scientific review groups and special emphasis panels. The meetings will be held virtually and are closed to the public due to the confidential nature of the discussions, which may involve trade secrets, commercial property, and personal information. The notice provides contact information for scientific review officers and details about the meeting agendas and formats.

View original listing